# A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

> **NCT01183559** · PHASE1 · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Cancer of the Esophagus
- Adenocarcinoma of the Gastroesophageal Junction
- Cancer of the Stomach

## Interventions

- **DRUG:** Vandetanib
- **DRUG:** 5 Fluorouracil (FU)
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **RADIATION:** External Beam Radiation Therapy (RT)

## Key facts

- **NCT ID:** NCT01183559
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-07
- **Primary completion:** 2010-11
- **Final completion:** 2011-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183559, "A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01183559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*